{
    "clinical_study": {
        "@rank": "105731", 
        "acronym": "Photopill", 
        "arm_group": {
            "arm_group_label": "Photopill treatment", 
            "arm_group_type": "Experimental", 
            "description": "Photopill treatment, 2 minutes per cm rectal mucosa (3cm) 10 times"
        }, 
        "brief_summary": {
            "textblock": "Photo-bio-stimulation by Low Level Light therapy(LLLT) has demonstrated its clinical use in\n      chemotherapy/radiotherapy oral mucositis.\n\n      Unpublished study (Melzer, Ben-Yehuda et al. UEGW 2012) with the Photopill (LLLT) capsule\n      treatment in mice showed a significant beneficial effect on the endoscopic severity of\n      DSS-induced colitis in mice.\n\n      Therefore a phase 1 trial is designed to assess the safety and feasibility of the Photopill\n      treatment in healthy volunteers."
        }, 
        "brief_title": "Photopill Treatment in Healthy Volunteers", 
        "completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "condition": "Ulcerated Mucosa of Colon", 
        "condition_browse": {
            "mesh_term": "Ulcer"
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Subjects who are generally healthy.\n\n          -  Signed informed consent.\n\n        Exclusion Criteria:\n\n          -  Subjects with any known GI related symptoms complaints or GI diseases.\n\n          -  Subjects with cancer or other life threatening diseases or conditions.\n\n          -  Subjects with cardiovascular or pulmonary diseases.\n\n          -  Pregnant women.\n\n          -  Subjects who underwent any colon surgery.\n\n          -  Morbid Obesity (BMI > 40).\n\n          -  Drug abuse or alcoholism.\n\n          -  Bed-ridden patient.\n\n          -  Any rectal therapy.\n\n          -  Participation in current clinical study or clinical study within 30 days    prior to\n             the study."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "4", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "October 3, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01702662", 
            "org_study_id": "METC2012_150, ABR: 40642"
        }, 
        "intervention": {
            "arm_group_label": "Photopill treatment", 
            "description": "2 courses of 5 Photopill treatments within 14 days. In each treatment, 3cm of rectal tissue will be exposed, 2 minutes per cm, to low level light therapy.", 
            "intervention_name": "Photopill treatment", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 10, 2012", 
        "location": {
            "facility": {
                "address": {
                    "city": "Amsterdam", 
                    "country": "Netherlands", 
                    "state": "Noord-Holland", 
                    "zip": "1105 AZ"
                }, 
                "name": "Academic Medical Center Amsterdam, department of Gastroenterology"
            }
        }, 
        "location_countries": {
            "country": "Netherlands"
        }, 
        "number_of_arms": "1", 
        "official_title": "The Assessment of the Photopill Capsule Treatment for Safety and Feasibility in Healthy Volunteers, a Phase 1 Trial", 
        "overall_official": {
            "affiliation": "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)", 
            "last_name": "Geert D'Haens, Prof.dr", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 1", 
        "primary_completion_date": {
            "#text": "October 2012", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Number of Participants with Adverse Events (Mucosal Aspect at 2nd sigmoidoscopy after 7-14 days) as a Measure of Safety and Tolerability", 
            "safety_issue": "Yes", 
            "time_frame": "During Study period: day 0-14"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01702662"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)", 
            "investigator_full_name": "Hanke Brandse", 
            "investigator_title": "MD, Phd student, executive investigator", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2012", 
        "study_design": "Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "December 2012"
    }
}